Therapeutic Potential of an Anti-diabetic Drug, Metformin: Alteration of miRNA expression in Prostate Cancer Cells |
Avci, Cigir Biray
(Department of Medical Biology, Ege University Medical School)
Harman, Ece (Department of Endocrinology, Izmir Katip Celebi University, Ataturk Training and Research Hospital) Dodurga, Yavuz (Department of Medical Biology, Pamukkale University Medical Faculty) Susluer, Sunde Yilmaz (Department of Medical Biology, Ege University Medical School) Gunduz, Cumhur (Department of Medical Biology, Ege University Medical School) |
1 | Baranwal S, Alahari SK (2010) miRNA control of tumor cell invasion and metastasis. Int J Cancer, 126, 1283-90. |
2 | Benjamini, Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B, 57, 289-300. |
3 | Ben SI, Laurent K, Loubat A, et al (2008). The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene, 27, 3576-86. DOI ScienceOn |
4 | Decensi A, Puntoni M, Goodwin P, et al (2010). Metformin and cancer risk in diabetic patients, a systematic review and meta-analysis. Cancer Prev Res, 3, 1451-61. DOI ScienceOn |
5 | De Hoon MJL, Imoto S, Nolan JN, Miyano S (2004). Open source clustering software. Bioinformatics, 20, 1453-4. DOI ScienceOn |
6 | Gotlieb WH, Saumet J, Beauchamp MC, et al (2008). In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecol Oncol, 110, 246-50. DOI ScienceOn |
7 | Hernes E, Kyrdalen A, Kvale R, et al (2010). Initial management of prostate cancer, first year experience with the Norwegian National Prostate Cancer Registry. BJU Int, 105, 805-11. DOI ScienceOn |
8 | Iorio MV, Croce CM (2009). MicroRNAs in cancer, small molecules with a huge impact. J Clin Oncol, 27, 5848-56. DOI ScienceOn |
9 | Isakovic A, Harhaji L, Stevanovic D, et al (2007). Dual antiglioma action of metformin, cell cycle arrest and mitochondria-dependent apoptosis. Cell Mol Life Sci, 64, 1290-302. DOI |
10 | Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49. DOI ScienceOn |
11 | Kong DJ, Li YW, Wang ZW, Banerjee S, et al (2009). miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells, 27, 1712-21. DOI ScienceOn |
12 | Landman GW, Kleefstra N, van Hateren KJ, et al (2010). Metformin associated with lower cancer mortality in type 2 diabetes, ZODIAC-16. Diabetes Care, 33, 322-6. DOI ScienceOn |
13 | Libby G, Donnelly LA, Donnan PT, et al (2009). New users of metformin are at low risk of incident cancer, a cohort study among people with type 2 diabetes. Diabetes Care, 32, 1620-5. DOI ScienceOn |
14 | Lin SL, Chiang A, Chang D, Ying SY (2008). Loss of mir-146a function in hormone-refractory prostate cancer. RNA, 14, 417-24. DOI ScienceOn |
15 | Mattie MD, Benz CC, Bowers J, et al (2006). Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer, 5, 24 DOI ScienceOn |
16 | Murtola TJ, Tammela TL, Lahtela J, et al (2008). Antidiabetic medication and prostate cancer risk, a population-based case-control study. Am J Epidemiol, 168, 925-31 DOI ScienceOn |
17 | Porkka KP, Pfeiffer MJ, Waltering KK et al (2007). MicroRNA expression profiling in prostate cancer. Cancer Res, 67, 6130-5. DOI ScienceOn |
18 | Schaefer A, Jung M, Kristiansen G, et al (2009). MicroRNAs and cancer, current state and future perspectives in urologic oncology. Urol Oncol, 28, 4-13. |
19 | Sharov AA, Dudekula DB, Ko MSH (2005). Principal component and significance analysis of microarrays with NIA Array Analysis tool. Bioinformatics, 21, 2548-9. DOI ScienceOn |
20 | Shi XB, Xue LR, Yang J, et al (2007). An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci USA, 104, 19983-88. DOI ScienceOn |
21 | Vrba L, Jensen TJ, Garbe JC, et al (2010). Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One, 5, 8697. DOI ScienceOn |
22 | Wright JL, Stanford JL (2009). Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. Cancer Causes Control, 20,1617-22. DOI ScienceOn |